Life sciences company focused on research and development of psychedelic medicines Lobe Sciences Ltd (CSE: LOBE) (OTCMKTS: GTSIF) announced having appointed Charles S. Grob, to the scientific advisory board of the company.
Cherles Grob is the MD investigator at the Lundquist Institute, he is also a Professor of Psychiatry & Biobehavioral Sciences and Pediatrics at the David Geffen School of Medicine at UCLA.
The company’s chief executive officer Phillip Young, made the announcement making it clear how the company was privileged to have someone with immense knowledge and experience as Grob on board. Previously, Grob has held several faculty positions at the Johns Hopkins School of Medicine and the University of California at Irvine
“We are honored to welcome Charles to our Scientific Advisory Board with his extensive background. Dr. Grob will add tremendous value to the team as we move forward with implementing our drug development platform,” said Young.